Back

Novel LiverRisk score is associated with adverse outcome in heart failure: insights from the BIOSTAT-CHF study

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Assessing risk in heart failure with novel biomarkers Comorbidities ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Mark Zhi Kang Tow

Dundee (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Impact of sarcopenia and osteopenia on prognosis in elderly heart failure patients: a computed tomography-based comparative study
Doctor S. Asami (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Evaluation of intracranial circulation in patients in terminal stage of heart failure before and after heart transplantation BRAIN-SAVE 2
Doctor J. Zizka (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Effects of pulmonary-artery-pressure-guided remote patient management in patients with heart failure with versus without depressive symptoms: insights from MEMS-HF
Professor C. Angermann (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
Obesity paradox in patients with heart failure with reduced ejection fraction across a wide body mass index spectrum: does it still exist in light of contemporary guideline-directed medical therapy?
Doctor T. Gergely (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Resting metabolism energy expenditure as a surrogate of muscle mass quantification in patients with heart failure and reduced ejection fraction: a pilot prospective cohort study
Doctor M. Sobral Domingues (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Assessing risk in heart failure with novel biomarkers

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
An Elevated FIB-4 Score is associated with the severity of heart failure
thumbnail
Congress Presentation
The prognostic role of fibrosis-4 score in heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Liver fibrosis and poor outcome in patients with heart failure: new insights from the BIOSTAT-CHF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources